BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 707348)

  • 1. Kinetics of serum 25-hydroxyvitamin D in patients with acute renal failure.
    Pietrek J; Kokot F; Kuska J
    Am J Clin Nutr; 1978 Oct; 31(10):1919-26. PubMed ID: 707348
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum 25-hydroxyvitamin D and parathyroid hormone in patients with acute renal failure.
    Pietrek J; Kokot F; Kuska J
    Kidney Int; 1978 Feb; 13(2):178-85. PubMed ID: 713278
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum 25-hydroxyvitamin D in patients with chronic renal disease.
    Pietrek J; Kokot F
    Eur J Clin Invest; 1977 Aug; 7(4):283-7. PubMed ID: 408149
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma 25-hydroxyvitamin D concentration in patients with hip fracture in Hong Kong.
    Lau EM; Woo J; Swaminathan R; MacDonald D; Donnan SP
    Gerontology; 1989; 35(4):198-204. PubMed ID: 2583533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcrystalline conjunctival calcification in renal failure. A useful clinical sign.
    Berlyne GM
    Lancet; 1968 Aug; 2(7564):366-70. PubMed ID: 4173787
    [No Abstract]   [Full Text] [Related]  

  • 6. Interrelation between plasma magnesium and 25 hydroxy-vitamin D3 levels in chronic renal failure.
    Shany S; Kushelevsky A; Berlyne GM
    Biomedicine; 1977 Apr; 26(2):108-11. PubMed ID: 871518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tromsø Heart Study: vitamin D metabolism and myocardial infarction.
    Vik T; Try K; Thelle DS; Førde OH
    Br Med J; 1979 Jul; 2(6183):176. PubMed ID: 466339
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bone demineralization in old age and vitamin D].
    Sonnenberg A; Sonnenberg GE; von Lilienfeld-Toal H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1353-5. PubMed ID: 611848
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum 25-hydroxyvitamin D and vitamin D-binding protein levels and mineral metabolism after partial and total gastrectomy.
    Imawari M; Kozawa K; Akanuma Y; Koizumi S; Itakura H; Kosaka K
    Gastroenterology; 1980 Aug; 79(2):255-8. PubMed ID: 6893189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical heterogeneity of calcitonin in renal failure.
    Lee JC; Parthemore JG; Deftos LJ
    J Clin Endocrinol Metab; 1977 Sep; 45(3):528-33. PubMed ID: 903401
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma concentrations of 25-hydroxycholecalciferol and anticonvulsant treatment].
    Baud L; Paunier L; Preece MA; O'Riordan JL; Sizonenko PC; Tchicaloff M
    Schweiz Med Wochenschr; 1974 Dec; 104(51):1908-10. PubMed ID: 4438987
    [No Abstract]   [Full Text] [Related]  

  • 12. Seasonal variations in serum 25-hydroxycholecalciferol in healthy people.
    McLaughlin M; Raggatt PR; Fairney A; Brown DJ; Lester E; Wills MR
    Lancet; 1974 Mar; 1(7857):536-8. PubMed ID: 4131976
    [No Abstract]   [Full Text] [Related]  

  • 13. 25-hydroxy-vitamin D, diet and sunlight exposure in patients admitted to a geriatric unit.
    Nayal AS; MacLennan WJ; Hamilton JC; Rose P; Kong M
    Gerontology; 1978; 24(2):117-22. PubMed ID: 618770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential changes in divalent ion metabolism after renal transplantation.
    Cotorruelo JG; De Francisco AL; Canga E; Amado JA; Riancho JA; Sanz de Castro S; Zubimendi JA; Arias M; González Macias J
    Transplant Proc; 1990 Aug; 22(4):1414-5. PubMed ID: 2389343
    [No Abstract]   [Full Text] [Related]  

  • 15. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 16. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
    LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
    N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on abnormalities of calcium, vitamin D and bone metabolism in patients on maintenance hemodialysis (author's transl)].
    Kitoh C
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):503-18. PubMed ID: 529620
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS; Piel CF; Gordan GS
    Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitamin D metabolism in hypoparathyroidism.
    Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
    J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.